Y-mAbs Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 24 U.S.-traded ETFs. YMAB has around 999.4K shares in the U.S. ETF market. The largest ETF holder of YMAB is the iShares Russell 2000 ETF (IWM), with approximately 444.98K shares. Investors may also find of interest that the ETF with the largest allocation to YMAB stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 5.29%. On average, U.S. ETFs allocate 0.30% of YMAB to their portfolios.
Additionally, YMAB is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with YMAB as a holding is the Vanguard Total Stock Market ETF (VTI), with a return of 9.53%.